84.39
0.95 (1.14%)
Previous Close | 83.44 |
Open | 83.43 |
Volume | 294,482 |
Avg. Volume (3M) | 365,027 |
Market Cap | 4,170,106,624 |
Price / Earnings (TTM) | 19.67 |
Price / Earnings (Forward) | 17.54 |
Price / Sales | 3.68 |
Price / Book | 2.25 |
52 Weeks Range | |
Earnings Date | 6 Aug 2025 - 11 Aug 2025 |
Profit Margin | 18.86% |
Operating Margin (TTM) | 34.03% |
Diluted EPS (TTM) | 4.29 |
Quarterly Revenue Growth (YOY) | 7.10% |
Quarterly Earnings Growth (YOY) | 1.40% |
Total Debt/Equity (MRQ) | 56.91% |
Current Ratio (MRQ) | 4.20 |
Operating Cash Flow (TTM) | 251.52 M |
Levered Free Cash Flow (TTM) | 188.69 M |
Return on Assets (TTM) | 6.50% |
Return on Equity (TTM) | 12.30% |
Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
Stock | Prestige Consumer Healthcare In | Mixed | Bullish |
AIStockmoo Score
Analyst Consensus | -2.0 |
Insider Activity | NA |
Price Volatility | 2.0 |
Technical Moving Averages | 1.0 |
Technical Oscillators | -0.5 |
Average | 0.13 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Small Core |
% Held by Insiders | 1.43% |
% Held by Institutions | 107.23% |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
17 Jun 2025 | Announcement | Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination |
09 Jun 2025 | Announcement | Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference |
08 May 2025 | Announcement | Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings |
10 Apr 2025 | Announcement | Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |